• Bayer to divest Animal Health unit for $7.6bn pharmaceutical-technology
    August 22, 2019
    Bayer has signed a definitive agreement to sell its Animal Health unit to US-based Elanco Animal Health for a total of $7.6bn, in a bid to focus on its core life sciences businesses.
PharmaSources Customer Service